Wuhan Golden Laser Co., Ltd (300220.SZ)
CNY 15.74
(1.81%)
CNY 15.74
(1.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.21 Million | -10.07 Million | -61.13 Million | -39.38 Million | 25.09 Million | 29.7 Million |
| Net Income | -27.34 Million | -54.18 Million | -64.33 Million | -57.62 Million | 15.8 Million | 7.84 Million |
| Depreciation & Amortization | 12.08 Million | 14.79 Million | 11.51 Million | 8.82 Million | 6.44 Million | 6.76 Million |
| Deferred income taxes | -6.7 Million | 16.29 Million | -5.4 Million | -4.8 Million | -3.14 Million | -109.94 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 17.79 Million | 27.77 Million | -34.78 Million | -18.2 Million | -1.94 Million | 11.14 Million |
| Other non-cash items | 3.49 Million | 1.54 Million | 26.47 Million | 27.61 Million | 4.78 Million | 3.95 Million |
| Investing Cash Flow | 47.43 Million | -6.05 Million | -10.21 Million | -20.82 Million | -18.09 Million | -5.49 Million |
| Investments in PPE | -1.59 Million | -3.03 Million | -13.41 Million | -6.8 Million | -21.11 Million | -7.34 Million |
| Acquisitions | - | 23.45 Thousand | 620.00 | -7.56 Million | 195 Thousand | 515.61 Thousand |
| Investment purchases | -14.65 Million | -9.9 Million | -2.6 Million | -9.92 Million | -4.32 Million | -79.4 Million |
| Sales/Maturities of investments | 63.68 Million | 6.86 Million | 5.8 Million | 8.44 Million | 6.98 Million | 80.7 Million |
| Other Investing Activities | 49.03 Million | 0.57 | 0.43 | -4.98 Million | 150.5 Thousand | 27.01 Thousand |
| Financing Cash Flow | -56.95 Million | 21.14 Million | 23.8 Million | 63.21 Million | -2.79 Million | -30.5 Million |
| Debt repayment | -18.4 Million | -21.4 Million | -80.5 Million | -24.7 Million | -17 Million | -20 Million |
| Dividends payments | -5.75 Million | -659.66 Thousand | -1.73 Million | -1.63 Million | -756 Thousand | -1.19 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -30.76 Million | 43.2 Million | 106.03 Million | 90.89 Million | 16.1 Million | -9.31 Million |
| Accounts receivables | -10.43 Million | 18.43 Million | -11.21 Million | 9.02 Million | -32.31 Million | -2.1 Million |
| Accounts payables | 29.77 Million | -15.48 Million | -8.94 Million | 28.88 Million | 21.67 Million | 6.97 Million |
| Inventory | 5.16 Million | 8.53 Million | -9.21 Million | -51.31 Million | 7.56 Million | 6.38 Million |
| Other working capital | 23.07 Million | 16.29 Million | -5.4 Million | -4.8 Million | 1.13 Million | 4.76 Million |
| Cash at beginning of period | 17.04 Million | 11.06 Million | 59.23 Million | 57.82 Million | 51.24 Million | 55.94 Million |
| Cash at end of period | 29.31 Million | 17.04 Million | 11.06 Million | 59.23 Million | 55.91 Million | 51.24 Million |
| Capital Expenditure | -1.59 Million | -3.03 Million | -13.41 Million | -6.8 Million | -21.11 Million | -7.34 Million |
| Effect of forex changes on cash | 574.14 Thousand | 969.17 Thousand | -637.12 Thousand | -1.58 Million | 476.66 Thousand | 1.59 Million |
| Net cash flow / Change in cash | 12.27 Million | 5.98 Million | -48.17 Million | 1.41 Million | 4.67 Million | -4.7 Million |
| Free Cash Flow | 19.61 Million | -13.11 Million | -74.55 Million | -46.19 Million | 3.98 Million | 22.36 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -281.55 Thousand | -1.82 Million | 3.12 Million | -27.34 Million | -15.92 Million | -5.33 Million |
| Depreciation & Amortization | - | 2.63 Million | 2.63 Million | 12.08 Million | 3.13 Million | -6.01 Million |
| Deferred income taxes | - | - | - | -6.7 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 17.79 Million | -5.27 Million | -11.59 Million |
| Other non-cash items | 9.61 Million | -4.05 Million | 4.69 Million | 3.49 Million | 23.91 Million | 42.17 Million |
| Investing Cash Flow | 4.19 Million | 6.74 Million | 561.63 Thousand | 47.43 Million | 14.19 Million | 31.75 Million |
| Investments in PPE | -113.7 Thousand | -198.97 Thousand | -360.77 Thousand | -1.59 Million | -1.25 Million | -36.07 Thousand |
| Acquisitions | 4398.00 | - | - | - | - | - |
| Investment purchases | -3 Million | - | -500 Thousand | -14.65 Million | -4.5 Million | -8.35 Million |
| Sales/Maturities of investments | 7.3 Million | 6.94 Million | 1.42 Million | 63.68 Million | 19.94 Million | 40.13 Million |
| Other Investing Activities | 4398.00 | - | 922.41 Thousand | 49.03 Million | 15.44 Million | - |
| Financing Cash Flow | -1.94 Million | -1.89 Million | -979.76 Thousand | -56.95 Million | -11.23 Million | -33.88 Million |
| Debt repayment | - | - | - | -18.4 Million | -18.4 Million | -18.4 Million |
| Dividends payments | - | - | -362.5 Thousand | -5.75 Million | -250 Thousand | -4.13 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.94 Million | -1.89 Million | -617.26 Thousand | -30.76 Million | -10.77 Million | -11.35 Million |
| Accounts receivables | - | - | - | -10.43 Million | -10.43 Million | -5.54 Million |
| Accounts payables | - | - | - | 29.77 Million | - | - |
| Inventory | - | - | - | 5.16 Million | 5.16 Million | -6.05 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 33.65 Million | 41.19 Million | 29.4 Million | 17.04 Million | 37.75 Million | 32.09 Million |
| Cash at end of period | 38.56 Million | 33.65 Million | 36.92 Million | 29.31 Million | 29.31 Million | 37.75 Million |
| Capital Expenditure | -113.7 Thousand | -198.97 Thousand | -360.77 Thousand | -1.59 Million | -1.25 Million | -36.07 Thousand |
| Effect of forex changes on cash | -34.45 Thousand | 461.37 Thousand | 146.6 Thousand | 574.14 Thousand | 209.19 Thousand | 42.2 Thousand |
| Net cash flow / Change in cash | 4.91 Million | -7.54 Million | 7.52 Million | 12.27 Million | -8.43 Million | 5.65 Million |
| Free Cash Flow | 9.22 Million | -8.7 Million | 7.45 Million | 19.61 Million | 3.59 Million | 19.19 Million |
CTRL
GR1T
TFCILTD
SUPREMEIND
VPLM
JUBLPHARMA